Copyright © 2012 Patrick S. Murphy and Gregory R. D. Evans. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. M. Trop, M. Novak, S. Rodl, B. Hellbom, W. Kroell, and W. Goessler, “Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient,” Journal of Trauma, vol. 60, no. 3, pp. 648–652, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
2. E. K. Mooney, C. Lippitt, and J. Friedman, “Silver dressings [safety and efficacy reports],” Plastic and Reconstructive Surgery, vol. 117, no. 2, pp. 666–669, 2006. View at Publisher · View at Google Scholar · View at PubMed
3. W. Stanford, B. W. Rappole, and C. L. Fox, “Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns,” Journal of Trauma, vol. 9, no. 5, pp. 377–388, 1969. View at Scopus
4. R. Warriner and R. Burrell, “Infection and the chronic wound: a focus on silver,” Advances in skin & wound care., vol. 18, pp. 2–12, 2005. View at Scopus
5. B. S. Atiyeh, M. Costagliola, S. N. Hayek, and S. A. Dibo, “Effect of silver on burn wound infection control and healing: review of the literature,” Burns, vol. 33, no. 2, pp. 139–148, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. R. Khundkar, C. Malic, and T. Burge, “Use of Acticoat dressings in burns: what is the evidence?” Burns, vol. 36, no. 6, pp. 751–758, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
7. G. L. McHugh, R. C. Moellering, C. C. Hopkins, and M. N. Swartz, “Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin,” The Lancet, vol. 1, no. 7901, pp. 235–240, 1975. View at Scopus
8. L. M. Deshpande and B. A. Chopade, “Plasmid mediated silver resistance in Acinetobacter baumannii,” BioMetals, vol. 7, no. 1, pp. 49–56, 1994. View at Scopus
9. A. T. Hendry and I. O. Stewart, “Silver-resistant enterobacteriaceae from hospital patients,” Canadian Journal of Microbiology, vol. 25, no. 8, pp. 915–921, 1979. View at Scopus
10. C. Haefeli, C. Franklin, and K. Hardy, “Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine,” Journal of Bacteriology, vol. 158, no. 1, pp. 389–392, 1984. View at Scopus
11. A. Gupta, K. Matsui, J. F. Lo, and S. Silver, “Molecular basis for resistance to silver cations in Salmonella,” Nature Medicine, vol. 5, no. 2, pp. 183–188, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
12. H. Q. Yin, R. Langford, and R. E. Burrell, “Comparative evaluation of the antimicrobial activity of Acticoat Antimicrobial Barrier Dressing,” Journal of Burn Care and Rehabilitation, vol. 20, no. 3, pp. 195–200, 1999. View at Publisher · View at Google Scholar · View at Scopus
13. J. B. Wright, K. Lam, and R. E. Burrell, “Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment,” American Journal of Infection Control, vol. 26, no. 6, pp. 572–577, 1998. View at Scopus
14. Y. Huang, X. Li, Z. Liao et al., “A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis,” Burns, vol. 33, no. 2, pp. 161–166, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. J. Fong, F. Wood, and B. Fowler, “A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits,” Burns, vol. 31, no. 5, pp. 562–567, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
16. E. E. Tredget, H. A. Shankowsky, A. Groeneveld, and R. Burrell, “A matched-pair, randomized study evaluating the efficacy and safety of acticoat silver-coated dressing for the treatment of burn wounds,” Journal of Burn Care and Rehabilitation, vol. 19, no. 6, pp. 531–537, 1998. View at Scopus
17. H. Liedberg and T. Lundeberg, “Assessment of silver-coated urinary catheter toxicity by cell culture,” Urological Research, vol. 17, no. 6, pp. 359–360, 1989. View at Scopus
18. P. K. Lam, E. S. Y. Chan, W. S. Ho, and C. T. Liew, “In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes,” British Journal of Biomedical Science, vol. 61, no. 3, pp. 125–127, 2004. View at Scopus
19. M. E. Innes, N. Umraw, J. S. Fish, M. Gomez, and R. C. Cartotto, “The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study,” Burns, vol. 27, no. 6, pp. 621–627, 2001. View at Publisher · View at Google Scholar · View at Scopus
20. L. C. Argenta and M. J. Morykwas, “Vacuum-assisted closure: a new method for wound control and treatment: clinical experience,” Annals of Plastic Surgery, vol. 38, no. 6, pp. 563–577, 1997. View at Scopus
21. L. C. Argenta, M. J. Morykwas, M. W. Marks, A. J. DeFranzo, J. A. Molnar, and L. R. David, “Vacuum-assisted closure: state of clinic art,” Plastic and Reconstructive Surgery, vol. 117, no. 7, pp. 127S–142S, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. M. L. Venturi, C. E. Attinger, A. N. Mesbahi, C. L. Hess, and K. S. Graw, “Mechanisms and clinical applications of the vacuum-assisted closure (VAC) device: a review,” American Journal of Clinical Dermatology, vol. 6, no. 3, pp. 185–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
23. H. M. Quah, A. Maw, T. Young, and D. J. Hay, “Vacuum-assisted closure in the management of the open abdomen: a report of a case and initial experiences,” Journal of Tissue Viability, vol. 14, no. 2, pp. 59–62, 2004. View at Scopus
24. M. Kaplan, “Managing the open abdomen,” Ostomy/Wound Management, vol. 50, no. 1, pp. C2–8, 2004. View at Scopus
25. D. Herscovici, R. W. Sanders, J. M. Scaduto, A. Infante, and T. DiPasquale, “Vacuum-assisted wound closure (VAC therapy) for the management of patients with high-energy soft tissue injuries,” Journal of Orthopaedic Trauma, vol. 17, no. 10, pp. 683–688, 2003. View at Publisher · View at Google Scholar · View at Scopus
26. M. K. Dobke, D. Nguyen, and S. A. Trott, “A novel approach to acute infection of the glenohumeral joint following rotator cuff repair—a case series,” Wounds, vol. 17, no. 6, pp. 137–140, 2005. View at Scopus
27. J. R. Heugel, K. S. Parks, S. S. Christie, J. F. Pulito, D. H. Zegzula, and N. A. Kemalyan, “Treatment of the exposed Achilles tendon using negative pressure wound therapy: a case report,” Journal of Burn Care and Rehabilitation, vol. 23, no. 3, pp. 167–171, 2002. View at Scopus
28. R. J. Morin and N. L. Tomaselli, “Interactive dressings and topical agents,” Clinics in Plastic Surgery, vol. 34, no. 4, pp. 643–658, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. S. L. Hansen, D. W. Voigt, P. Wiebelhaus, and C. N. Paul, “Using skin replacement products to treat burns and wounds,” Advances in Skin & Wound Care, vol. 14, no. 1, pp. 37–45, 2001. View at Scopus
30. C. Pham, J. Greenwood, H. Cleland, P. Woodruff, and G. Maddern, “Bioengineered skin substitutes for the management of burns: a systematic review,” Burns, vol. 33, no. 8, pp. 946–957, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. J. Noordenbos, C. Doré, and J. F. Hansbrough, “Safety and efficacy of TransCyte for the treatment of partial-thickness burns,” Journal of Burn Care and Rehabilitation, vol. 20, no. 4, pp. 275–281, 1999. View at Publisher · View at Google Scholar · View at Scopus
32. R. H. Demling and L. DeSanti, “Closure of partial-thickness facial burns with a bioactive skin substitute in the major burn population decreases the cost of care and improves outcome,” Wounds, vol. 14, no. 6, pp. 230–234, 2002. View at Scopus
33. J. F. Hansbrough, D. W. Mozingo, G. P. Kealey, M. Davis, A. Gidner, and G. D. Gentzkow, “Clinical trials of a biosynthetic temporary skin replacement, dermagraft-transitional covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds,” Journal of Burn Care and Rehabilitation, vol. 18, no. 1 I, pp. 43–51, 1997. View at Publisher · View at Google Scholar · View at Scopus
34. R. L. Spielvogel, “A histologic study of Dermagraft-TC in patients' burn wounds,” Journal of Burn Care and Rehabilitation, vol. 18, no. 1, pp. S16–S18, 1997. View at Scopus
35. I. Jones, L. Currie, and R. Martin, “A guide to biological skin substitutes,” British Journal of Plastic Surgery, vol. 55, no. 3, pp. 185–193, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
36. V. Falanga, D. Margolis, O. Alvarez et al., “Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent,” Archives of Dermatology, vol. 134, no. 3, pp. 293–300, 1998. View at Publisher · View at Google Scholar · View at Scopus
37. M. E. Gottlieb, “Management of complex and pathological wounds with Integra,” in The Wound Management Manual, pp. 226–289, McGraw-Hill, New York, NY, USA, 2004.
38. E. Lineen and N. Namias, “Biologic dressing in burns,” Journal of Craniofacial Surgery, vol. 19, no. 4, pp. 923–928, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. J. C. Jeng, P. E. Fidler, J. C. Sokolich et al., “Seven years' experience with integra as a reconstructive tool,” Journal of Burn Care and Research, vol. 28, no. 1, pp. 120–126, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. M. E. Gottlieb, “Histogenesis versus wound repair: the anatomy of Integra’s properties,” in Proceedings of the Boswick Burn and Wound Meeting, Maui, February 2003.
41. F. Cianfarani, R. Tommasi, C. M. Failla et al., “Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed,” British Journal of Dermatology, vol. 154, no. 1, pp. 34–41, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
42. R. Marques da Costa, F. M. Ribeiro Jesus, C. Aniceto, and M. Mendes, “Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers,” Wound Repair and Regeneration, vol. 7, no. 1, pp. 17–25, 1999. View at Publisher · View at Google Scholar
43. M. Cruciani, B. A. Lipsky, C. Mengoli, and F. De Lalla, “Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections? A meta-analysis,” Diabetes Care, vol. 28, no. 2, pp. 454–460, 2005. View at Publisher · View at Google Scholar · View at Scopus
44. S. A. L. Bennett and H. C. Birnboim, “Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor,” Molecular Carcinogenesis, vol. 20, no. 4, pp. 366–375, 1997. View at Publisher · View at Google Scholar · View at Scopus
45. D. L. Steed, M. W. Webster, J. J. Ricotta et al., “Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers,” Journal of Vascular Surgery, vol. 21, no. 1, pp. 71–81, 1995. View at Publisher · View at Google Scholar · View at Scopus
46. D. J. Margolis, C. Bartus, O. Hoffstad, S. Malay, and J. A. Berlin, “Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers,” Wound Repair and Regeneration, vol. 13, no. 6, pp. 531–536, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
47. D. P. Shackelford, E. Fackler, M. K. Hoffman, and S. Atkinson, “Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation,” American Journal of Obstetrics and Gynecology, vol. 186, no. 4, pp. 701–704, 2002. View at Publisher · View at Google Scholar · View at Scopus
48. D. B. Hom and J. C. Manivel, “Promoting healing with recombinant human platelet-derived growth factor-BB in a previously irradiated problem wound,” Laryngoscope, vol. 113, no. 9, pp. 1566–1571, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. S. Hunter, D. K. Langemo, J. Anderson, D. Hanson, and P. Thompson, “Hyperbaric oxygen therapy for chronic wounds,” Advances in Skin & Wound Care, vol. 23, no. 3, pp. 116–119, 2010. View at Scopus
50. J. V. Boykin, “Hyperbaric oxygen therapy: a physiological approach to selected problem wound healing,” Wounds, vol. 8, no. 6, pp. 183–198, 1996. View at Scopus
51. S. M. Bauer, R. J. Bauer, and O. C. Velazquez, “Angiogenesis, vasculogenesis, and induction of healing in chronic wounds,” Vascular and Endovascular Surgery, vol. 39, no. 4, pp. 293–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
52. O. C. Velazquez, “Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing,” Journal of Vascular Surgery, vol. 45, no. 6, pp. 39–47, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
53. O. M. Tepper, R. D. Galiano, J. M. Capla et al., “Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures,” Circulation, vol. 106, no. 22, pp. 2781–2786, 2002. View at Publisher · View at Google Scholar · View at Scopus
54. C. J. M. Loomans, E. J. P. De Koning, F. J. T. Staal et al., “Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes,” Diabetes, vol. 53, no. 1, pp. 195–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
55. M. Ii, H. Takenaka, J. Asai et al., “Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury,” Circulation Research, vol. 98, no. 5, pp. 697–704, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
56. S. R. Thom, V. M. Bhopale, O. C. Velazquez, L. J. Goldstein, L. H. Thom, and D. G. Buerk, “Stem cell mobilization by hyperbaric oxygen,” American Journal of Physiology, vol. 290, no. 4, pp. H1378–H1386, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
57. L. J. Goldstein, K. A. Gallagher, S. M. Bauer et al., “Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide,” Stem Cells, vol. 24, no. 10, pp. 2309–2318, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
58. K. A. Gallagher, L. J. Goldstein, S. R. Thom, and O. C. Velazquez, “Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing,” Vascular, vol. 14, no. 6, pp. 328–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
59. S. R. Jones, K. M. Carpin, S. M. Woodward et al., “Hyperbaric oxygen inhibits ischemia-reperfusion-induced neutrophil CD18 polarization by a nitric oxide mechanism,” Plastic and Reconstructive Surgery, vol. 126, no. 2, pp. 403–411, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
60. K. T. Khiabani, S. A. Bellister, S. S. Skaggs, L. L. Stephenson, C. Nataraj, and W. A. Zamboni, “Reperfusion-induced neutrophil CD18 polarization: effect of hyperbaric oxygen,” Journal of Surgical Research, vol. 150, no. 1, pp. 11–16, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
61. A. Gabriel, M. L. Porrino, L. L. Stephenson, and W. A. Zamboni, “Effect of L-arginine on leukocyte adhesion in ischemia-reperfusion injury,” Plastic and Reconstructive Surgery, vol. 113, no. 6, pp. 1698–1702, 2004. View at Publisher · View at Google Scholar · View at Scopus
62. W. A. Zamboni, H. P. Wong, L. L. Stephenson, and M. A. Pfeifer, “Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study,” Undersea and Hyperbaric Medicine, vol. 24, no. 3, pp. 175–179, 1997. View at Scopus
63. P. Kranke, M. Bennett, I. Roeckl-Wiedmann, and S. Debus, “Hyperbaric oxygen therapy for chronic wounds,” Cochrane Database of Systematic Reviews, no. 2, article CD004123, 2004. View at Scopus
64. M. Löndahl, P. Katzman, A. Nilsson, and C. Hammarlund, “Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes,” Diabetes Care, vol. 33, no. 5, pp. 998–1003, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
65. A. Abidia, G. Laden, G. Kuhan et al., “The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomized-controlled trial,” European Journal of Vascular and Endovascular Surgery, vol. 25, no. 6, pp. 513–518, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus